This topic contains a solution. Click here to go to the answer

Author Question: Having an international presence during the decline stage of the IPLC, particularly in developing ... (Read 44 times)

bio_gurl

  • Hero Member
  • *****
  • Posts: 524
Having an international presence during the decline stage of the IPLC, particularly in developing countries, is important.
 
 Indicate whether the statement is true or false

Question 2

_____ is the minimal level of stimulus intensity needed to detect a stimulus.
 A) Ambivalence
  B) The construal level
  C) The absolute threshold
  D) Credibility
  E) The subliminal level



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nguyenhoanhat

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

T
Having an international presence during the decline stage of the IPLC, particularly in developing countries, could be an advantage. The developing countries may be in a different stage of the product life cycle. In this way, the firm could be able to extend the product life cycle.

Answer to Question 2

C





 

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library